Inactive Instrument

OCTOPLUS Stock

Equities

NL0000345718

Biotechnology & Medical Research

End-of-day quote Euronext Amsterdam Other stock markets
- ^EUR	-

Press releases OCTOPLUS

OCTOPLUS : OctoPlus' Annual General Meeting of shareholders will be held on 28 June	13-06-13	PU
OCTOPLUS : ' Annual General Meeting of shareholders will be held on 28 June	13-06-13	GL
OCTOPLUS : Announces Delisting of Shares	13-03-15	GL
OCTOPLUS : Dr. Reddy's Holds 98.6% of the Shares in OctoPlus after the Post Closing Acceptance Period	13-02-28	BU
OCTOPLUS : Dr. Reddy’s holds 98.6% of the shares in OctoPlus after the Post Closing Acceptance Period	13-02-28	PU

More press releases

News in other languages on OCTOPLUS

OCTOPLUS : verkrijgt ontwikkelingscontract van internationaal farmaceutisch bedrijf	10-09-27
OCTOPLUS : verkrijgt productiecontract van Frans biotechnologie bedrijf	10-09-22
OCTOPLUS : tekent evaluatiecontract voor zijn technologie met Amerikaanse farmaceut	10-09-20
OCTOPLUS : tekent uitbreiding van evaluatiecontract voor zijn technologie met top-5 farmaceut	10-09-13
OCTOPLUS : maakt resultaten eerste halfjaar 2010 bekend	10-08-06

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+16.61%	122B
REGENERON PHARMACEUTICALS, INC.	+17.75%	112B
ARGENX SE	+17.23%	25.91B
BIONTECH SE	-24.11%	19.33B
GENMAB A/S	-18.56%	16.17B
BEIGENE, LTD.	-18.47%	15.6B
WUXI APPTEC CO., LTD.	-47.75%	14.65B
SAREPTA THERAPEUTICS, INC.	+57.35%	14.34B
NEUROCRINE BIOSCIENCES, INC.	+5.62%	14B

Bio Therapeutic Drugs

Protect and grow your investments with the help of our experts

Secure my Investments

fermer